Purpose To assess the validity, reliability, and responsiveness of the Spanish version of the
Expanded Prostate cancer Index Composite (EPIC) with 26 items. Methods Multicentric …

Methods Two hundred fifty-one participants completed a battery of self-report scales,
including the French-Canadian version of the EPIC, after having received radiation therapy …

Abstract Background The Expanded Prostate Index Composite for Clinical Practice (EPIC-
CP) is a short version of the original EPIC, developed to facilitate the instrument's use in …

Since 2006, our group has partnered with leading authors of the most used patient-related
outcomes questionnaires in prostate cancer. We have followed the international …

Methods This study is based on data collected prospectively between September 2014 and
February 2017 in Alberta, Canada. Men were treated with either radical prostatectomy or …

Purpose For patients with prostate cancer, validated and reliable instruments are essential
for measuring patient-reported outcomes. The aim of this study was to validate the German …

Abstract Background Recently, the Expanded Prostate Cancer Index Composite 26-item
version (EPIC-26) was recommended for the assessment of adverse effects after the …

Results The internal consistency of the EPIC was demonstrated by significant item-total
correlations and elevated Cronbach's alpha for each subscale (urinary: r=. 25-. 80; α=. 85; …

Objectives Validation of the Expanded Prostate Cancer Index Composite (EPIC)
questionnaire translated to Portuguese. This is an evaluation tool of the effects of treatment …

Objective To establish a score threshold that constitutes a clinically relevant change for each
domain of the Expanded Prostate Cancer Index Composite (EPIC) Short Form (EPIC-26) …